Advance Market Commitments - PowerPoint PPT Presentation

1 / 19
About This Presentation
Title:

Advance Market Commitments

Description:

The AMC guarantees, in advance, a reasonable price ... Choosing an AMC Pilot ... The administrative costs of implementing the AMC are expected to be low, with ... – PowerPoint PPT presentation

Number of Views:46
Avg rating:3.0/5.0
Slides: 20
Provided by: Slama
Category:

less

Transcript and Presenter's Notes

Title: Advance Market Commitments


1
Advance Market Commitments
Michel Zaffran Deputy Executive Secretary Chief
Technical / Policy Officer
2
Ensure Vaccine Availability
  • Buying and using existing products (GAVI, IFFIm)
  • Strengthening delivery systems to reach children
  • Increasing predictability of funding
  • Improving market for existing products
  • Preparing for future products (WHO, GAVI ADIPs,
    PPPs)
  • Provide data for timely national decision on
    demand
  • Improve accuracy of forecasting
  • Investing public resources in early RD
  • Product-development PPPs
  • Enterprise for scientific collaboration
  • Missing Assurance that the market for future
    products will exist in developing countries

3
Advance Market Commitments
  • The Problem
  • Industry wont invest in vaccines for small,
    risky and unpredictable markets
  • A Solution
  • Assurances of a future market
  • Provide credible commitments to guarantee future
    financing
  • Only use funds if vaccines are developed and
    demanded by countries

4
The AMC Mechanism
The AMC guarantees, in advance, a reasonable
price for the vaccine. The donor subsidy adds
to the small country co-pay and ensure firms can
make a return on investment if they develop and
supply the product.
12
10
Price
GuaranteedAMC price
8
6
AMC X billion
Contractually agreed Post-AMC price
4
2
Country Co-Financing
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Years
5
Choosing an AMC Pilot
  • Independent Expert Committee convened in February
    2006 to select the most suitable
    diseases/vaccines for an AMC pilot
  • 13 global experts in public health, epidemiology,
    industry economics, vaccine development and law
  • A majority from developing countries
  • The Expert Committee evaluated 6 candidates
    rotavirus, pneumococcal, human papillomavirus,
    malaria, HIV/AIDS and tuberculosis

6
Choosing an AMC Pilot
  • The Committee recommended pneumococcal disease as
    the most suitable candidate for an AMC pilot
  • The Committee recommended that a second
    demonstration AMC for a malaria vaccine be
    explored to stimulate early RD investment and to
    pilot the impact of the AMC on early stage
    vaccines

7
Pilot AMC Current Status
  • GAVI and The World Bank have worked with G8 to
    help design pneumococcal malaria pilot AMCs
  • Italy, Canada and the UK have accelerated plans
    to seek the support of other interested donors to
    launch a pilot and by the end of 2006
  • Over the coming months briefings and technical
    meetings will be organised at the initiative of
    these three countries to build support among
    interested donors

8
Implementing an AMC Pilot
  • The World Bank and GAVI have worked with G8 to
    help design the technical components for a pilot
  • Legal Framework
  • Framework Agreement
  • Guarantee Agreement
  • Financing Arrangements
  • Institutional Structure
  • AMC Secretariat
  • Independent Assessment Committee

9
1. Legal Framework
10
2. Financing Arrangements
  • The success of an AMC will depend on the
    credibility and strength of financing commitments
    by donors
  • Donor commitments will be bundled by the World
    Bank into a single financial instrument

11
3. Institutional Structure
  • The G8 requested an independent evaluation to
    consider the possible options for hosting an AMC
    Secretariat
  • The evaluation concluded that GAVI should serve
    as the secretariat to the AMC with specific
    functions in the World Bank
  • The administrative costs of implementing the AMC
    are expected to be low, with GAVI and the World
    Bank building on existing capacity

12
3. Institutional Structure, contd
  • Role of GAVI as the the programmatic leader on
    AMCs
  • Ensure technical support to developing countries
  • Provide linkages with immunisation stakeholders
  • Process eventual country applications and
    provision of vaccines to qualifying countries
  • Support the Independent Assessment Committee
    which will coordinate closely with existing WHO
    mechanisms (ECBS, SAGE, Prequalification)

13
3. Institutional Structure, contd
  • The World Bank would manage the financial and
    fiduciary functions of the AMC
  • Working with donors to structure financial
    commitments
  • Managing and disbursing funds to match vaccine
    payment schedules
  • GAVI and the Bank would share tasks such as
    negotiating the framework and guarantee
    agreements and reporting on the AMC

14
Risks (1) GAVI hosts the AMC Secretariat
  • The pilot does not work (inadequate demand, or
    industry doesnt respond)
  • Moderate risk
  • Pneumococcal vaccine selected to maximise
    probability for success
  • AMC funds are not released unless a vaccine meets
    specifications and countries demand the vaccine
  • Undermining GAVI decision-making processes
  • Low risk
  • The AMC determines if a vaccine will be made
    available rather than the details of how it will
    be provided

15
Risks (2) GAVI hosts the AMC Secretariat
  • Over-burdening the Secretariat
  • Moderate risk
  • Additional workload will support the Independent
    Assessment Committee
  • AMC Secretariat would require two additional
    full-time professionals
  • Additional governance structures not required
  • Perception that new vaccines are over funded
  • High risk
  • Current estimates suggest immunisation is
    dramatically under-funded
  • GAVIs country financing policies could mitigate
    risk

16
Risks (3) GAVI does not the AMC
  • AMC less likely to succeed
  • An opportunity for additional immunization
    resources and lives saved would be missed
  • Fragmentation of efforts for new vaccine
    introduction into developing countries
  • Two competing structures would provide new
    vaccines to developing countries
  • GAVI does not fulfill its mandate
  • The AMC is consistent with GAVI principles and
    plays to the strengths of the GAVI Alliance by
    drawing on the expertise of relevant Partners to
    implement

17
AMC Secretariat Implications for GAVI
  • If donors pledge funds to launch a pilot AMC in
    2007, the Board would be asked for guidance in
    setting up the Secretariat and determining the
    framework agreements
  • Additional support
  • 2 additional professionals to provide support to
    the Independent Assessment Committee and AMC
    Secretariat functions
  • Short-term legal support during 2007 to begin
    work on framework agreement, should donors signal
    an intention to launch

18
DECISION
The Executive Committees are requested to decide
whether the GAVI Secretariat should continue to
be involved in activities in support of an AMC
  • Option 1 (RECOMMENDED)
  • Agree to offer that the GAVI Secretariat hosts an
    AMC, should it be launched. The World Bank would
    be responsible for financial and fiduciary
    support and WHO would be instrumental in
    gathering experts and reviewing products.
  • Option 2
  • Do not agree to offer the GAVI Secretariat to
    host an AMC. This option would require
    development of a strategy to mitigate risks.

19
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com